Why work with us?

The Auckland Cancer Trials Centre is made up of a team of healthcare professionals, scientists and administrative staff members who are as passionate about their patients as they are about clinical research.  Positioned strategically within the orb of New Zealand’s leading city, referral hospital and university, ACTC offers sponsors an attractive and unique opportunity to trial their treatments.

An Experienced and Motivated Team

We have a dedicated team of doctors, nurses and clinical research coordinators who are GCP trained and highly experienced in the conduct of clinical research. Our team is enriched by the unique experience and skill set possessed by each staff member.

A Dedicated Clinical Research Facility within a Quaternary Hospital

Auckland City Hopital, is New Zealand’s largest public hospital and clinical research facility. It houses New Zealand’s leading health experts in a wide range of medical and surgical subspecialties.

ACTC is a purpose built clinical research facility with amenities for patient assessment/treatment and a micro-laboratory for rapid sample processing.

Embedded within Auckland City Hospital, ACTC benefits from the vast resources and clinical expertise available. This includes the hospital’s 24 hour acute care services, dedicated oncology inpatient unit, intensive care unit, comprehensive accredited laboratory and radiology facilities  and expert subspecialty input.

Auckland’s Regional Cancer and Blood Services

With a population of almost 1.7million, Auckland is New Zealand’s largest city and the country’s center of commerce and education. Beautifully situated with good public infrastructures, Auckland consistently ranks as one of the most liveable cities in the world. 

The Regional Cancer and Blood Services, based in Auckland City Hospital, is the sole public provider of cancer care in the  Auckland region. Auckland’s large, cosmopolitan and burgeoning population provides the service with a large and varied patient base.

Favourable Environment for Achieving Good Trial Enrolment

The Regional Cancer and Blood Services provides oncology care for 38% of all cancer patients in New Zealand. This includes all cancer streams. 

In addition, New Zealand’s judicious approach to funding novel anti-cancer therapy results in our patients having less access to new anti-cancer therapy when  compared to other OECD countries. This has created a mutually beneficial environment for both patients and sponsors. Restricted access to novel therapy makes clinical trial enrollment more attractive to patients and presents sponsors with a unique opportunity to trial their therapies in a niche environment. 

Quick Trial Startup Process

Applications for Health and Disability Ethics Committees (HDEC), Local/Institutional Ethics Board, and Standing Committee on Therapeutic Trial (SCOTT) approval in New Zealand can be done in tandem, resulting in shorter processing times. 

Moreover, at ACTC, our KPI and average startup time (completion and submission of documents to site initiation) is less than 100 days. We are open to enter negotiations on preferred site agreements. 

Proximity and a Dynamic Relationship with the University of Auckland 

The University of Auckland is New Zealand’s premier center of higher learning, with a thriving  healthcare research scene. The school of medicine and health sciences is located opposite Auckland City Hospital. The growing collaboration between scientist and clinicians is poised to create an excellent opportunity for the development of more translational studies in oncology/haematology.